Hong Kong IPO update: Dongpeng, Jintian Pharma, Goldpac
A lack of demand from retail investors has forced ceramic tile manufacturer Dongpeng Holdings to cut the price of its IPO, relaunching the deal on Tuesday at a fixed price that is 20%-35% below the original range. The all primary deal, which had been scheduled to price last Friday, will now raise HK$844m ($109m), down from a maximum of HK$1.1bn.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts